Multi-effect cream capable of promoting skin fibroblasts to secrete structural proteins

Abstract

The invention discloses a multi-effect cream capable of promoting skin fibroblasts to secrete structural proteins. The cream consists of, in parts by weight, 20-24 parts of elastin peptide liposome, 170-190 parts of water, 0.3-0.7 part of carbomer, 10-15 parts of glycerin, 1-2 parts of allantoin, 13-17 parts of mineral oil, 0.2-0.3 part of propyl hydroxybenzoate, 0.2-0.3 part of methyl hydroxybenzoate, 0.3-0.6 part of poly(dimethylsiloxane), 11-15 parts of cetostearyl alcohol, 0.07-0.1 part of essence, 0.8-1.5 parts of tocopheryl glycoside, 0.15-0.25 part of borneol, 2.5-3 parts of glyceryl monostearate, 1.0-1.5 parts of Tween 20, 6-9 parts of propylene glycol, 9-11 parts of shea butter, 0.4-0.6 part of ethylene diamine tetraacetic acid disodium salt and a proper amount of 2-amino-2-methyl-1-propanol. The elastin peptide liposome in the cream can be effectively absorbed by skins, so that the elasticity of facial skins can be recovered.

Description

Technical field [0001] The invention relates to the field of cosmetics, in particular to a multi-effect cream that promotes the secretion of structural proteins from skin fibroblasts. Background technique [0002] Skin elasticity is a problem that everyone faces. As we age, the loss of elastin is inevitable. Wrinkles due to lack of skin elasticity are one of the important skin problems that people are concerned about, and most of them are more effective in society. The method is surgery and prevention, and surgery is a method approved by a small number of people, and it is not very useful for people who have lost skin elasticity. [0003] In the prior art, by introducing elastin peptides into the cream, elastin peptide liposomes can directly enter the blood circulation of the face by promoting fibroblasts to produce elastin and collagen in the dermis of the skin, thereby restoring the skin to fullness. State of flexibility. However, because protein peptide drugs need to maintain ...

AI Technical Summary

Problems solved by technology

However, because protein and polypeptide drugs need to maintain the chemical structure of protein molecules to maintain their activity, they have poor stability, short half-life, poor membrane permeability, high clearance rate in the body, and are easily damaged by enzymes, bacteria and even body fluids. Non-injection administration The problem of extremely low bioavailability

Images